InvestorsHub Logo
icon url

Cosa

09/29/23 1:59 AM

#1321 RE: Whalatane #1319

Their last earnings the EPS was at (-$0.08) that's with Ibsrela alone. If Xphozah gets approved they could be positive by next year.